INO - Inovio Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
7,469
30,482
42,220
35,368
40,572
Cost of Revenue
-
-
-
-
0
Gross Profit
-
-
-
-
40,572
Operating Expenses
Research Development
95,094
95,258
98,573
88,712
57,792
Selling General and Administrative
25,253
29,315
28,290
23,892
18,064
Total Operating Expenses
120,347
124,573
126,863
112,604
75,856
Operating Income or Loss
-112,878
-94,091
-84,643
-77,236
-35,284
Interest Expense
-
-
-
-
-
Total Other Income/Expenses Net
-2,505
-1,628
-5,176
2,238
3,778
Income Before Tax
-117,015
-94,798
-88,206
-73,740
-31,201
Income Tax Expense
-170
2,170
0
0
-2,098
Income from Continuing Operations
-116,846
-96,968
-88,206
-73,740
-29,103
Net Income
-116,584
-96,968
-88,206
-73,740
-29,188
Net Income available to common shareholders
-116,584
-96,968
-88,206
-73,740
-29,188
Reported EPS
Basic
-
-1.05
-1.08
-1.01
-0.43
Diluted
-
-1.05
-1.09
-1.01
-0.44
Weighted average shares outstanding
Basic
-
92,540
81,777
73,215
68,198
Diluted
-
92,540
81,918
73,215
68,365
EBITDA
-
-89,094
-81,174
-74,150
-33,365